In order to examine the effect of increased IL-1 signaling in MPN progression, we performed exogenous IL-1β administration in heterozygous Jak2V617F (Jak2VF/+) knock-in mice that mainly exhibit a PV disease22. This evidence concerns the gene IL1A and myeloproliferative disorder.